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AbSTrACT
Bisphenol, used in many polycarbonate plastics and epoxy resins industries, exerts toxic effects on mammalian 
organs. The mechanisms underlying bisphenol toxicity are well understood, however the chemoprevention effects of 
L-carnitine have not yet been recorded. This study aimed to explore the protective mechanism of L-carnitine against 
BPA-induced hepatotoxicity. Male rats were randomly distributed into 4 groups of 10 rats each: vehicle (5 mL corn 
oil/kg), bisphenol (50 mg/kg b.w. orally), L-carnitine (500 mg/kg b.w. i/p), and L-carnitine bisphenol pre-treated 
groups. Bisphenol was dissolved in corn oil and gavaged for 70 consecutive days. Up-regulation of tumor necrosis 
factor (6.6-fold), and interleukin 6 (3.2-fold) mRNA transcript, along with suppression of nuclear factor erythroid 
2-like 2 (0.4-fold), were recorded, following bisphenol administration. Subsequently, bisphenol provoked oxidative 
stress and attenuated the antioxidative molecules. Finally, hepatic dysfunction was assessed by elevated serum 
aminotransferases, alkaline phosphatase, lactate dehydrogenase, glutamyl transferase activities and ammonia levels, 
with the subsequent decline in serum albumin concentration, which confirmed the inflammatory cell infiltration and 
hydropic degeneration, and the impairment of lipid profile. Interestingly, co-administration of L-carnitine improved 
liver function and lipid profile, which was explained by the activation of nuclear factor erythroid 2-like 2 (1.5-fold) 
mRNA transcript, which augmented the antioxidant levels and suppressed oxidative stress, tumor necrosis factor (2.6-
fold), and interleukin 6 (1.5-fold) gene expression. In conclusion, L-carnitine exerted hepatoprotective activity against 
bisphenol toxicity via antioxidant and anti-inflammatory effects.
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a change in acidic or alkaline conditions, it converts 
to the monomer form and is released into foods and 
water, causing human exposure risk (TALSNESS et 
al., 2009). Following absorption from the intestinal 
tract, BPA metabolizes in the liver to form BPA-
glucuronide which is chemically inert, and by the 
time it is accumulated, due to delayed elimination, 
Introduction
Bisphenol A (BPA), also known as 2,2-bis 
(4-hydroxyphenol) propane, has been widely used 
in the polycarbonate industries, plastic baby bottles, 
dental sealants, and the epoxy resin lining of beverage 
packaging and canned foods (VANDENBERG et 
al., 2009). BPA found in these products as a polymer 
is non-toxic, but when exposed to heat, UV light or 
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there is an increase in the free BPA concentration 
in the blood (VÖLKEL et al., 2002). BPA has toxic 
effects on the liver. In tests, it induced hepatic lipid 
accumulation in zebra fish and human hepatocytes 
(MARTELLA et al., 2016), disrupted the liver 
morphology and increased liver transaminases and 
lactate dehydrogenase enzymes (KORKMAZ et 
al., 2010). Also, BPA caused induction of hepatic 
DNA damage (EID et al., 2015), and hepatic 
tumors (WEINHOUSE et al., 2014). The signaling 
pathway underlying BPA-induced toxicity in 
different organs, including the liver, is the induction 
of reactive oxygen species (ROS) formation, and 
pro-inflammatory cytokines, and the suppression of 
the antioxidant system (KABUTO et al., 2004).
L-carnitine (L-β-hydroxy-γ-N-trimethyl 
aminobutyrate), a natural product, can be 
synthesized in the body from methionine and 
lysine amino acids, and has a pivotal role in fatty 
acid metabolism. It has been suggested that it 
prevents oxidative stress-induced mitochondrial 
damage and apoptosis (ALEISA et al., 2008). 
L-carnitine acts as a scavenger of reactive oxygen 
species, inhibiting mitochondrial dysfunction in 
hepatocarcinogenic rats (CHANG et al., 2005). 
Also, THANGASAMY et al. (2009) reported the 
powerful antioxidant activity of carnitine through 
the inhibition of lipid peroxidation. Further, it 
was found that supplementation of L-carnitine to 
hypercholesterolemic rats reduced the hepatic level 
of thiobarbituric acid reactive substances (TBARS) 
and increased GSH concentration (KESKIN et al., 
2015).
Nuclear factor erythroid-2-related factor-2 (Nrf2) 
is a nuclear transcriptional factor that binds DNA 
to the antioxidant response element and induces 
the transcription of the target genes encoding the 
antioxidant enzymes, thereby protecting cells 
from oxidative damage (WILLIAMSON et al., 
2012). Also, ROS production can activate pro-
inflammatory cytokine, tumor necrosis factor-α 
(TNF-α) and interleukin-6 (IL-6) gene expression 
and release (DONG et al., 1998). On the other hand, 
the production of these cytokines can motivate ROS 
generation (BABBAR and CASERO, 2006). To our 
knowledge, data regarding the mechanics of the 
effect of carnitine on bisphenol toxicity are scarce. 
Hence, the aim of the present study was to evaluate 
the chemo-protective and molecular effect of 
L-carnitine in long-term BPA-intoxicated rats, and 
the interplay of the antioxidant regulating master 
gene, Nrf2, oxidative stress and pro-inflammatory 
cytokine production.
Materials and methods
Chemicals and analytical reagents. Bisphenol A 







was purchased from Sigma-Aldrich Co., (St. Louis, 
MO, USA). L- Carnitine (β-hydroxy-γ-N-trimethyl 
aminobutyric acid; C7H15NO3) was obtained from 
mepaco-medifood Co., Egypt. Malondialdehyde 
(MDA), reduced glutathione (GSH), and total 
antioxidant capacity (TAC), glutathione peroxidase 
(GPX), catalase (CAT), and superoxide dismutase 
(SOD) kits were obtained from Bio diagnostic 
Co., Egypt. Biodiagnostic Kits of alanine 
aminotransferase (ALT), aspartate aminotransferase 
(AST), γ-glutamyl transferase (γ-GT), alkaline 
phosphatase (ALP), lactate dehydrogenase (LDH), 
ammonia, total protein, cholesterol, triacylglycerol 
(TAG), and low density lipoprotein cholesterol 
(LDL-c) were purchased from Vitro Scient Co., 
Egypt. The GF-1Total RNA Extraction Kit was 
delivered from Vivantis Co. Subang Jaya Malaysia. 
The One-step Rotor-Gene SYBR Green RT-PCR 
Master Mix was obtained from Qiagen, USA.
Animal and experimental design. Forty adult 
male albino rats, 3 months old, weighing 180 ± 
20 g were kindly provided by the Biochemistry 
Department, Faculty of Veterinary Medicine, 
Alexandria University. The rats were housed in 
stainless steel, wire bottom cages, with 14 hr light 
and 10 hr. dark, and adequate ventilation. They 
were fed standard diet pellets and allowed food and 
water ad libitum for an acclimation period of two 
weeks. The experiment was carried out according 
to the National Institute of Health guide for the care 
and use of Laboratory animals (NIH Publications 
No. 8023, revised 1978) and approved by the Ethics 
Committee at the Faculty of Veterinary Medicine, 
Alexandria University. The rats were randomly 
divided into 4 groups of 10 rats each, as following; 
the control received 5 mL/kg body weight vehicle 
(corn oil) by oral gavage daily, the BPA group was 
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treated orally with bisphenol at a dose of 50 mg/
kg body weight, dissolved in 5 mL corn oil kg/b.w. 
for 70 days for induction of hepatotoxicity, the 
L-carnitine-treated rats were administered 500 mg/
kg/day of L-carnitine via intraperitoneal injection, 
and the L-carnitine + BPA group was administered 
BPA and L-carnitine at the same doses and using 
the same route of administration. The BPA dose 
was chosen on the basis of previous experimental 
findings, toxicokinetics, the route of administration, 
and metabolic capacity (YILDIZ and BARLAS, 
2013). 
Blood and tissue collection. 24 hr after the 
last doses, the rats were anesthetized using an i/p 
injection of ketamine/xylazine, and blood samples 
were obtained from the retro-orbital sinus of the eye 
using heparinized capillary tubes, into two types 
of clean tubes, according to HOFF and RLAGT, 
(2000), one without anticoagulant for separation 
of sera, and the other containing anticoagulant 
for separation of plasma. Immediately after 
blood collection, the rats were then euthanized 
by decapitation under the previously specified 
anesthesia, according to the AVMA guidelines for 
euthanasia of animals, 2013 edition, and their livers 
were rapidly excised and divided into three parts; 
one part was preserved in 10% neutral buffered 
formalin for histological studies, the second 
was kept at -80 ºC for molecular examinations. 
The third part was homogenized using a glass 
homogenizer with ice-cooled saline to prepare 25% 
w/v homogenate. The homogenate was divided 
into two aliquots. The first one was deproteinized 
with ice-cooled 12% trichloroacetic acid and the 
supernatant obtained, after centrifugation at 1000 g, 
was used for estimation of the GSH content. The 
second aliquot was centrifuged at 1000 g and the 
resultant supernatant was used for estimation of 
levels of MDA, TAC, and antioxidant enzymes. 
Serum and plasma biochemical analyses. Liver 
functions were assessed by measuring the serum 
enzymatic biomarkers, ALT, AST, ALP, γ-GT, 
and LDH activities, along with plasma ammonia 
levels, according to the manufacturer’s instructions. 
Measurement of serum total protein, albumin, and 
lipid profile, TAG, total cholesterol, HDL-c, LDL-c, 
and VLDL-c were also performed according the 
manufacturer’s instructions. 
Oxidative/antioxidative parameters. Hepatic 
GSH levels were determined as described by the 
method of SEDLAK and LINDSAY (1968) using 
Ellman′s reagent, and expressed as nmol/g tissue. 
The level of the lipid peroxidation end products 
in the liver, on the basis of measurement of 
thiobarbituric acid-reactive substances (TBARS), 
was also evaluated according to the method 
described by OHKAWA et al. (1979), and expressed 
as nmol/g tissue. TAC in the liver was measured 
as described by KORACEVIC et al. (2001), and 
expressed as mmol/g tissue. The activities of 
enzymatic antioxidants were assayed and expressed 
as U/g tissue: CAT (ABEI, 1984), GPX (PAGLIA 
and VALENTINE, 1967), and SOD (KAKKAR et 
al., 1984).
qRT-PCR of hepatic Nrf2, TNF-α, and IL-6 
expression. Hepatic total RNA was isolated using a 
GF-1 Total RNA Extraction Kit (Vivantis, Malaysia) 
according to the manufacturer’s instructions. The 
yield of total RNA obtained was determined using 
a Nano Drop 2000 spectrophotometer (Thermo 
Fischer Scientific, USA). One step Rotor-Gene 
SYBR Green RT-PCR Master Mix (Qiagen, USA) 
was performed to estimate the relative quantitative 
determination of the gene expressions of Nrf2, 
TNF-α, and IL-6 mRNA level. Briefly, 12.5 µL of 
Rotor-Gene SYBR Green RT-PCR Master Mix, 
1 µL of forward primer, 1 µL of reverse primer 
(primer sequences are reported in Table 1), 0.25 
µL Rotor Gene RT mix, 2 µL RNA sample were 
combined, and the reaction completed up to 25 
µL with nuclease free water. The real time PCR 
device was programmed at 55 ºC for 10 min for 
cDNA synthesis, followed by 95 ºC for 5 min for 
inactivation of the reverse transcriptase enzyme. A 
total of 40 cycles were performed as follows: 95 
ºC/15s, 55 ºC/15s, 60 ºC/15s, followed by 60 ºC 
for 10 min. The relative expression was quantified 
relative to the expression of the reference gene 
(GAPDH) in the same sample, by calculating and 
normalizing the threshold cycle (Ct) values of the 
target genes to that of GAPDH, using the ΔΔCt 
method.
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Histopathological analyses. After necropsy, 
small liver specimens were collected from all 
the treated rats, and rapidly fixed in 10% neutral 
formalin for 24 hrs. After fixation, tissue specimens 
were processed using the conventional paraffin 
embedding technique. 5 µm thick sections were 
obtained from paraffin blocks, stained with 
hematoxylin and eosin, and examined under a light 
microscope (CULLING et al., 1985).
Statistical analysis. The data are expressed 
as the mean ± standard error of the mean (SEM). 
The data were analyzed using one-way analysis of 
variance (ANOVA), followed by post hoc multiple 
comparisons and Tukey’s HSD test. All data were 
analyzed using the SPSS statistical package version 
22.0 for Windows (IBM, Armonk, NY, USA). The 
level of significance was set at P<0.05.
results
Serum enzymatic biomarkers for assessment of 
liver function. The data presented in Table 2 reveal 
that rats intoxicated with BPA 50 mg/Kg bw had 
a significant increase in serum ALT (46.9 ± 0.96 
U/L), AST (276 ± 5.43 U/L), ALP (729 ± 15.4 
U/L), γ-GT (5.39 ± 0.44 U/L), and LDH (2653 ± 
89.1 U/L) activities when compared to the control. 
However, L-carnitine treatment non-significantly 
increased serum AST (217 ± 3.62 U/L), ALP (562 ± 
35.5 U/L), GGT (3.36 ± 0.3 U/L), and LDH (2195 
± 53. 3 U/L) activities, with a significant increase 
in serum ALT (39.5 ± 1.02 U/L) activity when 
compared to the control. Interestingly, treatment of 
BPA-intoxicated rats with L-carnitine significantly 
(P<0.05) decreased serum AST (245 ± 13.73 U/L), 
and ALP (647 ± 28.33 U/L) activities, with a non-
significant decrease in serum ALT (45.4 ± 1.58 U/L), 
GGT (5.19 ± 0.48 U/L), and LDH (2447 ± 132 U/L) 
activities when compared to the corresponding ones 
in the BPA-challenged rats.
Serum protein pattern and plasma ammonia 
level. Plasma ammonia (214 ± 5.73 µg/dL) levels 
increased significantly (P<0.05), with a significant 
Table 1 Primer sequence used for qRT-PCR
























Table 2. Serum hepatic enzyme biomarkers in rats treated with Bisphenol-A and L-carnitine
Parameter
Group
Control Bisphenol Carnitine Bisphenol + Carnitine
ALT U/L 34.8 ± 1.11c 46.9 ± 0.96a 39.5 ± 1.02b 45.4 ± 1.58a
AST U/L 197 ± 7.98c 276 ± 5.43a 217 ± 3.62c 245 ± 13.73b
ALP U/L 565 ± 12.3c 729 ± 15.4a 562 ± 35.5c 647 ± 28.33b
GGT U/L 2.45 ± 0.30b 5.39 ± 0.44a 3.36 ± 0.30b 5.19 ± 0.48a
LDH U/L 1986 ± 127c 2653 ± 89.1a 2195 ± 53.3bc 2447 ± 132ab
Values are means ± SE. Means without a common superscript in a row differ significantly (P<0.05). ALT - alanine transaminase; 
AST - aspartate transaminase; ALP - alkaline phosphatase; GGT - gamma glutamyl transferase; LDH - lactate dehydrogenase
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decrease in serum levels of albumin (2.44 ± 0.15 
g/dL), and A/G ratio (0.86 ± 0.09), and a non-
significant decrease in serum total protein (5.39 ± 
0.11 g/dL) concentration in the BPA-treated group, 
as compared to the control. Meanwhile, L-carnitine 
supplementation significantly increased serum total 
protein (6.84 ± 0.29 g/dL), and globulin (4.06 ± 0.24 
g/dL) concentrations, with a significant decrease in 
serum albumin (2.78 ± 0.08 g/dL) levels, and A/G 
ratio (0.70 ± 0.03), along with a non-significant 
change in serum ammonia levels (192 ± 3.58 µg/
dL) compared to the control rats. Additionally, 
BPA-intoxicated rats treated with carnitine showed 
a significant increase in serum total protein (6.46 ± 
0.18 g/dL), and globulin (3.86 ± 0.27 g/dL), with a 
significant decrease in serum ammonia levels (200 
± 3.03 µg/dL) and non-significant changes in serum 
albumin level and A/G ratio, when compared to the 
respective values in BPA-treated rats (Table 3).
Table 3. Effect of bisphenol and /or carnitine on serum protein patterns and plasma ammonia levels in rats
Parameter
Group
Control Bisphenol Carnitine Bisphenol + Carnitine
Total protein, g/dL 6.01 ± 0.26bc 5.39 ± 0.11c 6.84 ± 0.29a 6.46 ± 0.18ab
Albumin, g/dL 3.18 ± 0.16a 2.44 ± 0.15b 2.78 ± 0.08b 2.61 ± 0.14b
Globulin, g/dL 2.83 ± 0.27b 2.95 ± 0.15b 4.06 ± 0.24a 3.86 ± 0.27a
A/G ratio 1.23 ± 0.17a 0.86 ± 0.09b 0.70 ± 0.03b 0.72 ± 0.09b
Ammonia, µg/dL 197 ± 4.53b 214 ± 5.73a 192 ± 3.58b 200 ± 3.03b
Values are means ± SE. Means without a common superscript in a row differ significantly (P<0.05). A/G ratio - albumin to globulin 
ratio
Table 4. Serum lipid profile in rats treated with Bisphenol-A and L- carnitine 
Parameter
Group
Control Bisphenol Carnitine Bisphenol + Carnitine
Cholesterol, mg/dL 80.8 ± 1.56b 91.4 ± 3.06a 85.1 ± 3.55b 83.3 ± 3.39b
TAG, mg/dL 147 ± 1.17c 168 ± 1.41a 156 ± 2.07b 161 ± 2.11b
HDL-c, mg/dL 35.5 ± 1.28a 20.1 ± 1.19c 38.4 ± 1.04a 32.0 ± 1.22b
LDL-c, mg/dL 15.9 ± 2.61b 27.8 ± 2.53a 15.6 ± 2.81b 19.2 ± 3.64b
VLDL-c, mg/dL 29.31 ± 0.23c 33.5 ± 0.28a 31.2 ± 0.41b 32.1 ± 0.42b
Values are means ± SE. Means without a common superscript in a row differ significantly (P<0.05). TAG - triacylglycerol; HDL-c- 
high density lipoprotein cholesterol; LDL-c - low density lipoprotein cholesterol; VLDL-c - very low density lipoprotein cholesterol
Table 5. Hepatic MDA, TAC, and GSH levels in rats treated Bisphenol-A and L-carnitine
Parameter
Group
Control Bisphenol Carnitine Bisphenol + Carnitine
MDA, nmol/g tissue 107 ± 4.01c 146 ± 3.86a 100 ± 2.19c 134 ± 1.67b
TAC, mmol/g tissue 14.9 ± 0.89a 9.75 ± 0.43c 15.0 ± 0.97a 12.3 ± 0.62b
GSH, nmol/g tissue 54.3 ± 2.81a 39.1 ± 1.62b 44.6 ± 2.64b 42.9 ± 2.46b
GPX, U/g tissue 23.17 ± 0.23 11.08 ± 0.25 35.21 ± 0.22 20.04 ± 0.55
CAT, U/g tissue 512.12 ± 3.16 121.72 ± 2.3 501.5 ± 3.11 331.37 ± 2.6
SOD, U/g tissue 126.23 ± 1.18 73.92 ± 1.1 147.12 ± 1.2 121.13 ± 1.2
Values are means ± SE. Means without a common superscript in a row differ significantly (P<0.05). MDA - malondialdehyde; TAC- 
total antioxidant capacity; GSH - reduced glutathione; GPX - glutathione peroxidase; CAT - catalase; SOD - superoxide dismutase
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Fig. 2. Photomicrograph of hepatic tissue stained with H&E 200 nm. (A); Normal hepatic architecture (arrow), (B); 
Bisphenol-treated rats showed severe hydropic degeneration (arrow) and inflammatory cell infiltration (arrow head), 
(C); L-carnitine supplemented group revealed normal pathology (arrow), and (D) L-carnitine pretreated bisphenol 
group showed single cell necrosis (arrow head) and mild periportal mononuclear cell infiltrations (arrow).
Fig. 1. Fold change of hepatic Nrf2, TNF-α, and IL-6 mRNA transcript. *Significant differ from control at P<0.01; 
**Significant differ from control at P<0.01; # significant differ bisphenol group at P<0.05. BPA; bisphenol, LCA; L-carnitine, 
LCA+BPA; L-carnitine pretreated bisphenol group, Nrf2; nuclear factor erythroid 2-like 2, TNF-α; tumor necrosis factor alpha, 
IL-6; interleukin 6.
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Serum lipid profile. Serum total cholesterol 
(91.4 ± 3.06 mg/dL), TAG (168 ± 1.41 mg/dL), 
LDL-c (27.8 ± 2.53 mg/dL), and VLDL-c (33.5 ± 
0.28 mg/dL) increased significantly while serum 
HDL-c (17.1 ± 1.19 mg/dL) was significantly lower 
(P<0.05) in BSA-challenged rats, as compared to 
the control values (Table 4). Treatment of BSA-
intoxicated rats with L-carnitine significantly 
increased serum total cholesterol, and HDL-c 
levels, with decreased serum TAG, and VLDL-c 
levels, and without change in serum LDL-c levels, 
when compared to the BSA-treated rats.
Oxidative/antioxidative profile. Bisphenol 
A induced oxidative stress, as indicated by the 
significant increase in hepatic MDA levels (146 
± 3.86 nmol/g tissue), with attenuation of TAC 
(9.75 ± 0.43 mM/g tissue), GSH (39.1 ± 1.62 mg/ 
g tissue), GPX (- 52%), CAT (- 66%), and SOD (- 
41%) when compared to the control. Meanwhile, 
L-carnitine significantly (P<0.05) decreased the 
concentration of hepatic MDA (134 ± 1.67 nmol/g 
tissue), increased the TAC level (12.3 ± 0.62 mM/g 
tissue), GPX (+ 80%), CAT (+ 172%), and SOD (+ 
64%) with an insignificant increase in hepatic GSH 
levels (42.9 ± 2.46 mg/g tissue) compared to those 
in BPA-intoxicated rats (Table 5).
Hepatic Nrf2, TNF-α, and IL-6 mRNA transcript. 
Nrf2 mRNA transcript expression in hepatic 
tissue in the BPA-treated group was significantly 
lower(-50%) as compared to the control. However, 
treatment of rats with L-carnitine significantly 
increased Nrf2 mRNA transcript (1.8-fold) in the 
liver when compared to the control. Interestingly, 
co-administration of BPA with L-carnitine 
significantly increased (1.5-fold) the expression of 
Nrf2 mRNA transcript in comparison with BSA-
intoxicated rats (Fig. 1). 
Conversely, BPA significantly activated the gene 
expression of TNF-α (6.6-fold), and IL-6 (2.6-fold) 
in relation to the control. Meanwhile, L-carnitine 
significantly reduced TNF-α (3.2-fold), and Il-6 
(1.5-fold) mRNA transcript as compared to BPA-
challenged rats, indicating its anti-inflammatory 
activity. 
Histopathological findings. Normal hepatocytes 
arranged in cords around the central vein (arrow) 
were observed in the control rats (Fig. 2A) 
However, the hepatic cells of the BSA-treated rats 
showed mononuclear inflammatory cell infiltration 
(arrowhead) in the periportal area, associated 
with severe hydropic degeneration (arrow) of 
the hepatocytes (Fig. 2B). On the other hand, the 
L-carnitine-treated group showed normal hepatic 
architecture (arrow) (Fig. 2C). However, the livers 
of the BPA-challenged rats showing single cell 
necrosis (arrowhead) associated with mild periportal 
mononuclear inflammatory cell infiltration (arrow) 
(Fig. 2D).
discussion
The present study showed the hepatic alterations 
induced by long-term exposure to high doses of BPA, 
by means of analysis of liver enzymatic activities, 
lipid profile, oxidant/antioxidant biomarkers, and 
gene expression of Nrf2. Furthermore, we studied 
whether L-carnitine administration could minimize 
the adverse effects of BPA. This study revealed that 
BPA induced liver damage, represented by elevated 
liver enzyme: (ALT, AST, ALP, LDH and γ-GT), 
and ammonia levels, with a decline in the serum 
albumin level, confirmed by our histopathological 
findings. Our results coincided with other previous 
studies based on the elevation of serum ALT, AST, 
ALP activities, and bilirubin level, along with the 
decline in the serum total protein and albumin 
levels in BPA-challenged rats (EZEONU et al., 
2015). Also, VAHDATI HASSANI et al. (2017) 
demonstrated BSA-induced liver injuries through 
elevated serum AST, and LDH enzymes, with 
periportal inflammation and necrosis. Leakage of 
the liver enzymes AST, and LDH as the result of 
disruption of the hepatocellular plasma membrane, 
may be a biomarker for inflammatory and 
necrotic injuries (GIANNINI et al., 2005). These 
findings were confirmed recently by KAMEL et 
al. (2018), who found that BPA induced hepatic 
necrotic changes, vacuolar degeneration, sinusoid 
dilatation, and nuclei pyknosis. Further, fatty 
degeneration, inflammatory cell infiltration, 
vacuolar degeneration, and congestion of blood 
vessels are considered the main characteristics 
of BPA toxicity, besides biochemical elevation 
of serum AST, ALT, and bilirubin concentration 
(ABDEL SAMIE et al., 2017). L-carnitine intake 
improved the liver function and histopathological 
findings compared to the BPA group. Parallel to this 
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result, CAYIR et al. (2009) showed that L-carnitine 
obviously attenuated sinusoidal dilatation, 
leukocyte infiltration, and hepatocyte cytoplasmic 
changes in cisplatin-treated rats. Also, L-carnitine 
co-treatment with methotrexate produced mild 
congestion, vacuolation of hepatocytes, and 
decreased the apoptotic cells, and serum ALT and 
AST enzymatic activities (TOUSSON et al., 2014). 
Furthermore, rats fed a high cholesterol diet and 
treated with L-carnitine showed a significant decline 
in serum ALT, AST, ALP, and GGT enzymatic 
activities, supporting the notion of the prevention of 
hepatic injuries and enzyme leak (KESKIN, 2015). 
The hepatoprotective role of L-carnitine may be 
attributed to its direct antioxidant effect, or to the 
augmentation of endogenous antioxidative defenses.
The present study suggests that BPA induces lipid 
metabolism disorders, since the serum TAG, total 
cholesterol, VLDL-c, and LDL-c increased, while 
serum HDL-C levels decreased, indicating hepatic 
lipid accumulation and liver damage. Increased 
serum triacylglycerol, fatty acid synthesis, and 
glucose concentration were reported with different 
doses of BPA in mice (MARMUGI et al., 2012). 
Meanwhile, ABDEL-WAHAB, (2014) showed the 
elevation of serum TAG, cholesterol, and LDL-c 
levels, along with HDL-c level decline following 
4 weeks of BPA administration. MOGHADDAM 
et al. (2015) found high levels of serum TAG, total 
cholesterol, LDL-c and glucose and a low level 
of HDL-c in BSA-intoxicated rats. In this study, 
L-carnitine protected the liver from the damaging 
effects of BPA, via improvement of the serum 
lipid profile. This result was in agreement with 
MALAGUARNERA et al. (2010), who found 
that L-carnitine ameliorated the blood glucose, 
TAG, cholesterol, and lipoprotein concentrations 
in NASH patients. Also, pemphigus valugaris 
patients had low levels of serum total cholesterol, 
TAG, and LDL-c without any change in HDL-c 
level, following L-carnitine administration 
(MOHAMMADI et al., 2018). The reduction in 
the serum LDL-c concentration may be attributed 
to the enhancement of LDL receptor expression 
by L-carnitine (YOUSEFINEJAD et al., 2015). 
Moreover, L-carnitine reduced the serum TAG, and 
VLDL-c levels, interceded through augmentation 
of the peroxisome proliferator activated receptor 
(PPAR-α), and carnitine palmitoyltransferase-1 
(CPT-1) gene expression, resulting in the activation 
of fatty acid oxidation (YOUSEFINEJAD et al., 
2018). It was reported recently that L-carnitine 
supplementation reduced the serum total cholesterol 
and TAG concentration and muscle oxidative stress 
via regulation of PPAR-γ mRNA expression in 
chronically exercised rats (PALA et al. 2018). 
It has been noted that BPA-induced 
hepatotoxicity is mediated through the induction 
of oxidative stress, which is the primary cause 
of cell membrane injuries and leakage of marker 
enzymes (MOON et al., 2012), lipid accumulation, 
and hepatic inflammation (HUC et al., 2012). Our 
results revealed the accumulation of hepatic lipid 
byproducts, MDA, besides low GSH and TAC 
concentrations, and antioxidant enzymatic activities 
coinciding with down-regulation of Nrf2 mRNA and 
up-regulation of TNF-α, and IL-6 gene expression. 
BPA increased the expression and serum levels of 
TNF-α, and IL-6 in HepG2 cells, suggesting the 
contribution of these cytokines to oxidative stress 
induction and mitochondrial dysfunction (MOON 
et al., 2012). These results were in parallel with 
those of KAZEMI et al. (2017) who proved the 
link between induction of oxidative stress and BPA 
accumulation. KORKMAZ et al. (2010) suggested 
that BPA-induced liver injuries may be attributed to 
an oxidative/antioxidative imbalance. The lipophilic 
property of BPA was incriminated in the induction 
of oxidative stress, which reacts with the lipophilic 
cell membrane, instigating OH radical formation, 
and creating lipid peroxidation (SUTHAR et 
al., 2014). The explanation of low GSH levels in 
the BPA-treated group may be attributed to the 
exhaustion of GSH for ROS scavenging. This 
result coincides with HASSAN et al. (2012), who 
reported that BPA resulted in attenuation of GSH 
levels and SOD activity. Recently, KAMEL et al. 
(2018) recorded elevated hepatic MDA levels, 
along with a significant decrease in SOD, and GSH 
levels in BSA-treated rats. We suggest that BPA-
induced pro-inflammatory cytokines associated 
with the generation of oxidative stress, along 
with the suppression of Nrf2 and depletion of 
enzymatic and non-enzymatic antioxidants, are the 
central mechanism contributing to BPA-induced 
hepatic damage. Our hypothesis correlates with 
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the results of WAHBY et al. (2017) who ascribed 
the hepatic damage caused by BPA to the induction 
of TNF-α, resulting in an increase in oxidative 
stress and a decline in GSH levels and antioxidant 
enzymatic activities. The principal mechanism 
of the protective effect of L-carnitine against 
BPA-induced hepatotoxicity could be mediated 
through the induction of endogenous antioxidative 
molecules. The hepatoprotective activity of some 
natural products is mediated through free radical 
scavenging activity, or via induction of Nrf2-
augmented antioxidant gene expression (AL-
RASHEED et al., 2016). The protective effect of 
L-carnitine against bisphenol toxicity is due to 
its antioxidant and anti-inflammatory activities 
(MANSOUR, 2006). L-carnitine has the ability 
to inhibit the inflammatory signaling pathway in 
some hepatic inflammatory conditions and fibrosis 
(ANNADURAI et al., 2011). The anti-inflammatory 
activity of L-carnitine could be attributed to the 
attenuation of NF-KB, the principal activator of 
most pro-inflammatory cytokines as TNF-α and 
interleukins. This explanation coincides with the 
recent findings of BODAGHI-NAMILEH et al. 
(2018) who mentioned that co-administration of 
carnitine with arsenic, down-regulated NF-KB 
expression, suggesting the anti-inflammatory 
activity of carnitine and suppression of oxidative 
stress. Recently, L-carnitine supplementation was 
found to diminish interleukins levels in aspartame 
induced toxicity in rats (HAMZA et al., 2019). 
In the same context, EL-SHERBINI et al. (2017) 
attributed the protective role of L-carnitine against 
lead toxicity to ROS production attenuation and 
free radical scavenging activities via augmentation 
of antioxidant enzymes. Also, FATEN et al. (2013) 
suggested the protective activity of L-carnitine 
against methotrexate-induced oxidative insult 
via improvement of hepatic GSH levels, and 
enzymatic antioxidant activities. A recent study 
showed the antioxidative activity of L-carnitine 
in streptozotocin-induced diabetic rats through the 
inducement of antioxidants, GSH, CAT, GPX, and 
SOD, and by decreasing MDA production (SAMIR 
et al., 2018). Upregulation of the Nrf2 pathway was 
conducted through L-carnitine treatment, indicating 
its crucial role in H2O2-induced oxidative stress 
(WANG et al., 2017). L-carnitine may produce 
evanescent ROS within the cells which may be 
incriminated in ROS-activated Nrf2 induction 
(ZAMBRANO et al., 2013). Interestingly, a recent 
study recorded that acetyl-l-carnitine serves as 
an Nrf2 inducer, preventing the oxidative stress 
in lenses (LIU et al., 2017). In the same context, 
YANG et al. (2015) reported that acetyl-l-carnitine 
suppressed ROS production and cell death in vitro, 
by activation of CAT, GPX, SOD, and GSH gene 
expression via the Nrf2/Keap1 pathway.
It was concluded that L-carnitine plays a pivotal 
role in the induction of Nrf2, and down-regulation 
of pro-inflammatory cytokine expressions reflected 
the activation of antioxidative enzymes and GSH, 
and suppression of oxidative stress, which is the 
principal hepatoprotective activity of L-carnitine 
against BSA-induced liver toxicity, besides 
improvement of lipid metabolism. 
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SAžetAk
Bisfenol, koji se koristi u mnogim industrijama polikarbonatne plastike i epoksidnih smola, ima toksične učinke na 
organe sisavaca. Mehanizmi na kojima se temelji toksičnost bisfenola dobro su razumljivi, međutim učinci L-karnitina 
na kemoprevenciju još nisu zabilježeni. Cilj ovog ispitivanja bio je istražiti zaštitni mehanizam L-karnitina protiv 
hepatotoksičnosti izazvane BPA-om. Mužjaci štakora slučajnim su odabirom podijeljeni u su u 4 skupine od po 10 
štakora: kontrolna skupina (5 mL kukuruznog ulja/kg tjelesne težine), duga skupina (50 mg bisfenol/kg tjelesne težine 
peroralno), teća skupina (500 mg L-karnitin/kg tjelesne težine i/p) i četvrta skupina (L-karnitin apliciran skupini 
prethodno tretiranoj bisfenolom). Bisfenol je otopljen u kukuruznom ulju kojim su štakori hranjeni 70 uzastopnih 
dana. Nakon primjene bisfenola zabilježeno je povećanje mRNK transkripta za stvarnje faktora tumorske nekroze i 
interleukina 6 uz supresiju nukleotidnog faktora sličnog eritroidu 2, povezanog s faktorom 2. Nakon toga bisfenol je 
izazvao oksidativni stres i oslabio antioksidativne molekule. Naposljetku, disfunkcija jetre procjenjivana je povišenim 
razinama aminotransferaza u serumu, alkalne fosfataze, laktat dehidrogenaze, aktivnosti glutamiltransferaze i 
amonijaka, uz naknadno smanjenje koncentracije serumskog albumina, što je potvrdilo infiltraciju upalnih stanica 
i hidropičnu degeneraciju, te narušavanje lipidnog statusa. Zanimljivo je da je istodobna primjena L-karnitina 
poboljšala funkciju jetre i lipidni status, što je objašnjeno aktivacijom transkripta mRNK tipa 2 povezanog s faktorom 
2, koji je povećao razine antioksidansa i potisnuo oksidativni stres, te ekspresiju gena faktora tumorske nekroze i 
interleukina 6. Zaključno, L-karnitin je pokazao hepatozaštitnu aktivnost protiv toksičnosti bisfenola antioksidativnim 
i protuupalnim učincima.
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